Logo

LabCorp Receives the US FDA's Emergency Use Authorization for its COVID-19 At-Home Test Kit

Share this

LabCorp Receives the US FDA's Emergency Use Authorization for its COVID-19 At-Home Test Kit

Shots:

  • The EUA allows nasal swab specimens to be collected at home using Pixel by LabCorp COVID-19 test home collection kit if recommended by HCPs following the completion of the COVID-19 questionnaire. The test has been authorized to detect nucleic acid from SARS-CoV-2- not for any other viruses or pathogens
  • LabCorp’s COVID-19 at-home test kit helps to prevent the risk of transmitting the virus to others and reduces the demand for PPE as the tests do not require a clinician to perform the test collection
  • The Kit will be initially available to HCPs and first responders who have been exposed to COVID-19 or may be symptomatic and is expected to be available to the consumer in the coming weeks

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: LabCorp


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions